Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Bigespas Ltd

Clinical trials sponsored by Bigespas Ltd, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New hope for Alzheimer's? phase 3 trial of DMB-I begins Results expected May 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New hope for Alzheimer's? phase 3 trial of DMB-I begins

Disease control Recruiting now

This study tests whether the drug DMB-I (latrepirdine) can improve thinking and memory in people with mild to moderate Alzheimer's dementia. About 450 adults aged 60-90 will take either DMB-I, a placebo, or an active comparator for 26 weeks. Researchers will compare changes in co…

Phase 3 • Sponsor: Bigespas LTD • Aim: Disease control

Last updated Jun 27, 2026 08:03 UTC